Insider Trading July 24, 2026 09:30 PM

TCG Crossover GP II Reduces Surrozen Stake with $6.9M Share Sale

The 10% owner and director of Surrozen Inc. executed two separate sales of 162,500 shares each on July 22, 2026, at $21.25 per share, while disgorging short-swing profits as mandated by securities regulations.

By Priya Menon
Share
Twitter Reddit Facebook LinkedIn
SRZN

TCG Crossover GP II, LLC, acting as a 10% owner and director of Surrozen Inc. (NASDAQ: SRZN), completed a significant divestiture by selling 325,000 shares of common stock on July 22, 2026. The total transaction value reached $6,906,250, with each share priced at $21.25. In compliance with Section 16(b) of the Securities Exchange Act of 1934, the reporting entities have fully disgorged the short-swing profits generated from these sales back to Surrozen Inc. The transaction structure involved two identical sales of 162,500 shares each, executed on the same date. Following these dispositions, TCG Crossover GP II, LLC indirectly maintains a holding of 574,054 shares through TCG Crossover Fund II, L.P., and 574,047 shares through TCG Crossover Fund III, L.P. Chen Yu, serving as the sole managing member of TCG Crossover GP II, LLC, retains shared voting, investment, and dispositive power over these securities. Similarly, Chen Yu acts as the sole managing member of TCG Crossover GP III, LLC, the general partner of TCG Crossover Fund III, L.P., holding identical control powers over that entity's holdings.

TCG Crossover GP II Reduces Surrozen Stake with $6.9M Share Sale
SRZN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • TCG Crossover GP II, LLC sold 325,000 shares of Surrozen Inc. on July 22, 2026, at $21.25 per share, totaling $6,906,250.
  • The reporting entities disgorged all short-swing profits to Surrozen Inc. in compliance with Section 16(b) of the Securities Exchange Act of 1934.
  • Chen Yu retains shared voting, investment, and dispositive power over the remaining indirect holdings through TCG Crossover Fund II, L.P. and TCG Crossover Fund III, L.P.

TCG Crossover GP II, LLC, a 10% owner and director of Surrozen, Inc. (NASDAQ: SRZN), executed a significant divestiture of equity stakes in the company. On July 22, 2026, the entity sold a total of 325,000 shares of common stock. The aggregate value of these transactions reached $6,906,250. Each share was disposed of at a price of $21.25. The transaction structure consisted of two separate sales, each comprising 162,500 shares, both finalized on July 22, 2026, at the specified price point.

Regulatory compliance was a key component of these transactions. As of the filing date, the reporting persons have disgorged the full amount of short-swing profits realized from these sales to Surrozen, Inc. This action fulfills the requirements mandated by Section 16(b) of the Securities Exchange Act of 1934. The disposal of these shares has altered the indirect holding structure of the reporting entities. Following the transactions, TCG Crossover GP II, LLC indirectly holds 574,054 shares through TCG Crossover Fund II, L.P. Additionally, the entity holds 574,047 shares through TCG Crossover Fund III, L.P.

Control and governance structures remain tightly held. TCG Crossover GP II, LLC serves as the general partner for TCG Crossover Fund II, L.P. Chen Yu is identified as the sole managing member of TCG Crossover GP II, LLC. Chen Yu shares voting, investment, and dispositive power over these securities. Similarly, TCG Crossover GP III, LLC acts as the general partner of TCG Crossover Fund III, L.P. Chen Yu is also the sole managing member of this entity, sharing voting, investment, and dispositive power over the associated securities.

Market context surrounding the sale indicates recent volatility. The stock trades at $19.72, reflecting a decline of over 10% in the past week. Despite this recent downward trajectory, shares have surged 120% over the past year. Valuation metrics present a complex picture. According to InvestingPro analysis, the stock appears overvalued at current levels. However, analysts maintain price targets between $40 and $44, suggesting divergent views on fair value.

Post-market activity showed slight movement. The stock closed at 19.730, with a change of 0.000 (0.00%). After hours trading recorded a price of 19.73, down 1.430 (-6.76%) at 16:10:04. The broader market context includes a 1D change of -1.430 (-6.76%). The 1W change reflects the recent decline, while the 1M, 6M, 1Y, and 5Y timeframes provide longer-term performance data. The Max timeframe offers the widest historical perspective.

Risks

  • The stock has declined over 10% in the past week, trading at $19.72, indicating recent downward pressure.
  • Analyst valuation metrics suggest the stock appears overvalued at current levels, despite maintained price targets between $40 and $44.
  • The discrepancy between the sale price of $21.25 and the current trading price of $19.72 highlights potential volatility and pricing risk.

More from Insider Trading

Motorcar Parts Executive Divests Entire Stake in Post-Earnings Surge Jul 24, 2026 Coherent CFO Executes $306,680 Stock Sale Under Pre-Arranged Trading Plan Jul 24, 2026 Immunovant Director Atul Pande Executes Pre-Arranged Share Sale Amid Strong Analyst Sentiment Jul 24, 2026 Block Director Anthony Eisen Executes $1.4 Million Share Sale Amid Analyst Optimism Jul 24, 2026 Intellia CFO's Mandatory Stock Sale Reflects Routine Compliance Amid Analyst Divergence Jul 24, 2026